PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26711482-0	2016	Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.	Oxcarbazepine	64-77	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	25-29	
26711482-2	2016	Auto-induction potentials of oxcarbazepine, its pharmacologically active metabolite 10-hydroxyoxcarbazepine and carbamazepine were evaluated by cytochrome P450 (CYP) 1A2, CYP2B6 and CYP3A4 mRNA levels and primary metabolic rates using human hepatocytes and HepaRG cells.	Oxcarbazepine	29-42	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	171-177	
26711482-4	2016	The fold change in mRNA levels for CYP2B6 was 11.5 (3.2-19.3), 7.0 (2.5-10.8) and 14.8 (3.1-29.1) for oxcarbazepine, 10-hydroxyoxcarbazepine and carbamazepine, respectively.	Oxcarbazepine	102-115	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	35-41	
26711482-9	2016	The 10-keto group instead of double bond at C10 position is evidently a determinant factor for limited auto-induction of P450 enzymes by oxcarbazepine.	Oxcarbazepine	137-150	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	121-125